This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: The Innovations of Shoaqing Chen
Introduction
Shoaqing Chen is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of type 2 diabetes mellitus. His work has led to the development of innovative compounds that hold promise for improving patient outcomes.
Latest Patents
Shoaqing Chen holds a patent for Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors. The patent includes compounds of formula I, along with pharmaceutically acceptable salts and esters thereof. These compounds are designed to target specific biochemical pathways involved in type 2 diabetes, showcasing Chen's commitment to advancing medical science.
Career Highlights
Chen is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role at the company allows him to collaborate with other talented professionals in the field. His work has been instrumental in the development of new therapeutic options for patients suffering from diabetes.
Collaborations
Some of his notable coworkers include Yimin Qian and Steven Gregory Mischke. Their collective expertise contributes to the innovative environment at Hoffmann-La Roche Inc., fostering advancements in pharmaceutical research.
Conclusion
Shoaqing Chen's contributions to the field of diabetes treatment through his patented innovations highlight his role as a key inventor in the pharmaceutical industry. His work continues to pave the way for new therapeutic solutions that can significantly impact patient care.